Krazati 200 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DR26F9AP1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,310
Award facts
- Contract value 100% obligated
- $13,309.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,309.58 on November 6, 2025, for the supply of Krazati 200 mg tablets (180-unit quantity). This firm fixed-price, competitively awarded contract is non-set-aside and requires delivery by December 1, 2025, to the company's facility in Conshohocken, Pennsylvania. Krazati is an oncology medication, reflecting the breadth of pharmaceutical products the federal government procures through its medical supply chain to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical support vehicle valued through December 2026 that enables the company to supply medications and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the DLA, providing brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9AP1?
SPE2DR26F9AP1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F9AP1 worth?
The government has obligated $13,310 on SPE2DR26F9AP1.
Is contract SPE2DR26F9AP1 an order under another contract?
Yes. SPE2DR26F9AP1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AP1 competed?
The extent of competition for SPE2DR26F9AP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award